GSK plc
F:GS71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for GSK plc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What GSK Does
In the heart of the pharmaceutical landscape, GSK plc stands as a venerable institution that intertwines scientific discovery with patient well-being. Originally founded as GlaxoSmithKline, the company has navigated the evolving demands of healthcare with a deft blend of innovation and strategic acumen. As a major player in the global healthcare sector, GSK operates within three principal segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.
- Headquarters
- United Kingdom UK
- Employees
- 90 096
- IPO date
- May 22, 1972
Balance Sheet
Recent Events
Latest Earnings Call
GSK reiterated its 2026 outlook as specialty medicines drove momentum, the late-stage pipeline accelerated and restructuring moved ahead.
Open the earnings call- EPS
- €0.44
- Expected
- €0.51
- Surprise
- −13.2%
- Stock, next trading day
- −0.6%
Past 12 months
Continue GS71 Research
Decided on GSK? Get an email when GS71 reaches the price you’d buy at. Free with an account.